Last reviewed · How we verify

Jiedu Huayu Oral Prescription — Competitive Intelligence Brief

Jiedu Huayu Oral Prescription (Jiedu Huayu Oral Prescription) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Hepatology.

phase 3 Hepatology Small molecule Live · refreshed every 30 min

Target snapshot

Jiedu Huayu Oral Prescription (Jiedu Huayu Oral Prescription) — Beijing Tiantan Hospital. Jiedu Huayu Oral Prescription is a traditional Chinese medicine formulation designed to detoxify and resolve blood stasis, potentially improving hepatic fibrosis and cirrhosis outcomes.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Jiedu Huayu Oral Prescription TARGET Jiedu Huayu Oral Prescription Beijing Tiantan Hospital phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Jiedu Huayu Oral Prescription — Competitive Intelligence Brief. https://druglandscape.com/ci/jiedu-huayu-oral-prescription. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: